Zonal responsiveness of the human intervertebral disc to bone morphogenetic protein-2

Spine (Phila Pa 1976). 2009 Aug 1;34(17):1834-8. doi: 10.1097/BRS.0b013e3181ae18ba.

Abstract

Study design: In vitro experiment using bone morphogenetic protein-2 (BMP-2) and cells from the nucleus pulposus (NP), transitional zone (TZ), and anulus fibrosus (AF) of the human intervertebral disc (IVD).

Objective: To demonstrate the differential effect of BMP-2 on DNA synthesis, proteoglycan synthesis, and osteocalcin mRNA expression in human IVD cells from the NP, TZ, and AF, respectively.

Summary of background data: BMP-2 has been proven to be effective in stimulating proteoglycan synthesis in articular chondrocytes and IVD cells from the NP. Nevertheless, the effect of BMP-2 on cells from different regions of the IVD has not yet been thoroughly elucidated.

Methods: Human IVDs were harvested from surgical disc procedures and tissue from the NP, TZ, and AF was obtained. Disc tissue was enzymatically digested, and IVD cells were cultured three-dimensionally in alginate beads. Then IVD cell cultures from the NP, TZ, and AF were exposed to BMP-2. DNA synthesis and newly synthesized proteoglycan were measured. Reverse transcription-polymerase chain reaction for mRNA expression of bone sialoprotein, DLX5, osteocalcin, and collagen type I, was performed.

Results: Cells from the AF responded to BMP-2 with mitogenesis. There was no significant increase in DNA synthesis in cultures from the NP and TZ treated with BMP-2. Only cells from the NP showed a significant increase in newly synthesized proteoglycan in response to BMP-2. IVD cells from all zones demonstrated no significant expression of bone sialoprotein, DLX5, osteocalcin mRNA after treatment with BMP-2.

Conclusion: BMP-2 clearly exerted a mitogenic effect on AF cells, and stimulated proteoglycan synthesis in NP cells. However, BMP-2 did not have an osteogenic effect in any IVD region. Taken together, these results confirm that BMP-2 can be used as an anabolic agent for mitogenesis in AF cells and NP cell matrix regeneration without the possibility of osteogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Bone Morphogenetic Protein 2 / metabolism
  • Bone Morphogenetic Protein 2 / pharmacology*
  • Bone Morphogenetic Protein 2 / therapeutic use
  • Cells, Cultured
  • Chondrocytes / drug effects
  • Chondrocytes / metabolism
  • Collagen Type I / genetics
  • DNA / biosynthesis
  • DNA / drug effects
  • Extracellular Matrix / drug effects
  • Extracellular Matrix / metabolism
  • Homeodomain Proteins / genetics
  • Humans
  • Intervertebral Disc / drug effects*
  • Intervertebral Disc / metabolism*
  • Intervertebral Disc / physiopathology
  • Intervertebral Disc Displacement / drug therapy*
  • Intervertebral Disc Displacement / metabolism*
  • Intervertebral Disc Displacement / physiopathology
  • Middle Aged
  • Osteocalcin / genetics
  • Osteopontin / genetics
  • Proteoglycans / drug effects
  • Proteoglycans / genetics
  • Proteoglycans / metabolism
  • RNA, Messenger / drug effects
  • RNA, Messenger / metabolism
  • Regeneration / drug effects*
  • Regeneration / physiology
  • Transcription Factors / genetics
  • Up-Regulation / drug effects
  • Up-Regulation / genetics

Substances

  • BMP2 protein, human
  • Bone Morphogenetic Protein 2
  • Collagen Type I
  • DLX5 protein, human
  • Homeodomain Proteins
  • Proteoglycans
  • RNA, Messenger
  • Transcription Factors
  • Osteocalcin
  • Osteopontin
  • DNA